RxSight Inc. is a medical technology company that specializes in developing innovative solutions for vision care. The company was founded in 1996 by Dr. Daniel Schwartz, a leading ophthalmologist and researcher, with a vision to transform the field of cataract surgery. RxSight is headquartered in Aliso Viejo, California, USA.
RxSight's flagship product is the Light Adjustable Lens (LAL), which is designed to revolutionize cataract surgery. The LAL is the first intraocular lens (IOL) that allows for post-operative adjustments to be made to the lens power, enabling personalized vision correction for each patient. This unique feature sets the LAL apart from traditional fixed-focus IOLs used in cataract surgery and provides patients with the potential for improved visual outcomes without the need for additional surgical procedures.
The Light Adjustable Lens works through a proprietary process called Light Adjustable Refractive Index (LARI). After the cataract surgery, the surgeon uses ultraviolet (UV) light to activate the photosensitive material within the lens, which modifies its refractive power. This adjustment process occurs outside the patient's eye, and once the desired correction is achieved, the lens becomes stable, providing long-lasting vision improvement.
The Light Adjustable Lens offers benefits to both patients and surgeons, as it provides enhanced flexibility and precision in achieving the desired visual outcomes after cataract surgery. Patients who undergo cataract surgery with the LAL can experience reduced dependence on glasses and achieve better visual acuity for various distances. Additionally, the lens can be adjusted even years after the initial surgery, allowing for vision refinement as needed over time.
RxSight's dedication to innovative technologies in the field of ophthalmology has positioned the company as a key player in the vision care industry. By continually advancing their product offerings and expanding their global presence, RxSight aims to improve the quality of life for patients undergoing cataract surgery and address unmet needs in the vision care market.